{
  "id": 19839254,
  "title": "Intensified liver-directed radionuclide therapy shows promise for patients with metastatic neuroendocrine tumors",
  "url": "https://urgent.news/2026/11/13/intensified-liver-directed-radionuclide-therapy-shows-promise-for",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-13T16:40:07.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-liver-radionuclide-therapy-patients-metastatic.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Combining intraarterial and intravenous administration of peptide receptor radionuclide therapy (PRRT) can selectively intensify treatment for liver-dominant metastatic neuroendocrine tumors (NETs) while still effectively delivering treatment throughout the whole body. This hybrid approach safely delivered over three times more radiation directly to liver metastases, resulting in encouraging…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}